Innospec

Elementis Rebuffs Innospec Approach

UK specialty chemicals company Elementis has been the subject of another attempted takeover – its fourth in under six months – but this time from US rival, Innospec.

News

Innospec Says Expects To Settle Bribe Probes

Top-Feature

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

CHEManager International c/o Wiley-VCH GmbH

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Interview

Interconnected Global Chemicals Logistics

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

The Valence Group

Innospec

Elementis Rebuffs Innospec Approach

Huntsman Sells European Surfactants to Innospec

Innospec Completes Sale of Widnes to Emerald

Ex-Innospec Execs Found Guilty of Bribes to Sell Toxic Additives

Innospec Aims for Sub-$300 Million Acquisition by March End

Chemical Companies are Continuing to Seek Growth Opportunities

TPC Group Gets Higher Offer from First Reserve, SK Capital

TPC Group Gets Higher Buyout Offer from Innospec

Ex-Innospec UK Director Guilty Of Iraq Corruption

Innospec Says Expects To Settle Bribe Probes

Top-Feature

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Upcoming Virtual Events

Siemens Joins the Global Impact Coalition

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Interview

Driving Transformation

Innospec

Top-Feature

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Upcoming Virtual Events

Siemens Joins the Global Impact Coalition

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Interview

Newsletter & e-edition